Nair A, Chung HC, Sun T, Tyagi S, Dobrolecki LE, Dominguez-Vi dana R, et al. Combinatorial inhibition of PTPN12-regulated receptors lead s to a broadly eﬀective therapeutic strategy in triple-negative breast can cer.Nat Med.(2018)24:505–11.doi:10.1038/nm.4507 79. Reinhardt C, Zdrojowy R, Szczylik C, Ciuleanu T, Brugger W, Obe rneder R, et al. Results of a randomized phase II study investigating multipe ptide vaccination with IMA901 in advanced renal cell carcinoma (RCC) .J Clin Oncol.(2010)28:4529.doi:10.1200/jco.2010.28.15_suppl.4529 80. Wick W, Dietrich P-Y, Kuttruﬀ S, Hilf N, Frenzel K, Admon A, et al. GAPVAC-101: ﬁrst-in-human trial of a highly personalized pept ide vaccinationapproachforpatientswithnewlydiagnosedglioblasto ma.JClin Oncol.(2018)36:2000.doi:10.1200/JCO.2018.36.15_suppl.2000 81. Bassani-Sternberg M, Gfeller D. Unsupervised HLA peptidome deconvolutionimprovesligandpredictionaccuracyandpredictscoopera tive eﬀects in peptide-HLA interactions. J Immunol. (2016) 197:2492–9. doi:10.4049/jimmunol.1600808 82. Gfeller D, Bassani-Sternberg M. Predicting antigen presentat ion-what could we learn from a million peptides? Front Immunol. (2018) 9:1716. doi:10.3389/ﬁmmu.2018.01716 83. Bhagwandin VJ, Bishop JM, Wright WE, Shay JW. The metastati c potential and chemoresistance of human pancreatic cancer stem cells. PLoS ONE.